Varex Imaging Corporation (VREX) Reports Q4 EPS of $0.29, Revenues Beat; Offers FY19 Revenue Outlook Below Consensus
Varex Imaging Corporation (NASDAQ: VREX) reported Q4 EPS of $0.29, versus $0.00 reported last year. Revenue for the quarter came in at $205 million versus the consensus estimate of $192.1 million.
Quarterly Highlights
- Revenues decreased 5% to $205 million
- Gross margin was 29% | Adjusted gross margin* was 33%
- Operating earnings margin was 3% | Adjusted operating earnings margin* was 10%
- Net earnings were $0.01 per diluted share | Adjusted net earnings* were $0.29 per diluted share
"While our revenues for the fourth quarter of fiscal year 2018 decreased from record revenues in the prior year quarter, revenues increased 7% sequentially from the third quarter of fiscal year 2018 driven by growth in the CT, mammography and industrial markets," said Sunny Sanyal, Chief Executive Officer of Varex Imaging Corporation. "In the fourth quarter, we continued to see pressure on our gross margins and we began to be directly impacted by China-related tariffs. We estimate that tariffs reduced our gross profit by $2 million for the quarter," Sanyal added.
GUIDANCE:
Varex Imaging Corporation sees FY2019 EPS of $1.25-$1.55, versus the consensus of $0.00. Varex Imaging Corporation sees FY2019 revenue of $755-780 million, versus the consensus of $785.9 million.
For earnings history and earnings-related data on Varex Imaging Corporation (VREX) click here.
